Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience

Objective: This aim of this study is to assess the ovulation induction cycles based on clomiphene citrate and gonadotropin administration and specify the factors associated with successful outcomes. Study Design: This is a prospective study of 631 patients who underwent 917 ovulation induction cy...

Full description

Saved in:
Bibliographic Details
Main Authors: Beril Gurlek, Ali Sertac Batioglu, Mine Kanat-Pektas, Ibrahim Kale, Ozgur Onal, Nafiye Yilmaz-Karakas
Format: Article
Language:English
Published: Medical Network 2020-03-01
Series:Gynecology Obstetrics & Reproductive Medicine
Subjects:
Online Access:https://gorm.com.tr/index.php/GORM/article/view/978
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857259428446208
author Beril Gurlek
Ali Sertac Batioglu
Mine Kanat-Pektas
Ibrahim Kale
Ozgur Onal
Nafiye Yilmaz-Karakas
author_facet Beril Gurlek
Ali Sertac Batioglu
Mine Kanat-Pektas
Ibrahim Kale
Ozgur Onal
Nafiye Yilmaz-Karakas
author_sort Beril Gurlek
collection DOAJ
description Objective: This aim of this study is to assess the ovulation induction cycles based on clomiphene citrate and gonadotropin administration and specify the factors associated with successful outcomes. Study Design: This is a prospective study of 631 patients who underwent 917 ovulation induction cycles. While clomiphene citrate was used in 680 cycles (74.2%) and recombinant follicle-stimulating hormone was administered in 237 cycles (25.8%). Results: A total of 153 pregnancies were achieved in 917 ovulation induction cycles, indicating a clinical pregnancy rate of 16.7%. The ovulation induction cycles which ended up with clinical pregnancy had a significantly lower frequency of smoking (p=0.005), shorter infertility duration (p=0.001), higher basal luteinizing hormone (p=0.021) and lower basal progesterone (p=0.008) than unsuccessful cycles. The clomiphene citrate cycles which ended up with clinical pregnancy had a significantly lower frequency of smoking (p=0.011), shorter infertility duration (p=0.001) and lower basal progesterone (p=0.013) than the unsuccessful cycles. The recombinant follicle-stimulating hormone cycles which ended up with clinical pregnancy had a significantly higher basal luteinizing hormone (p=0.008) than the unsuccessful cycles. Basal luteinizing hormone and progesterone concentrations could significantly distinguish the patients who were able to conceive in ovulation induction cycles (p=0.021 and p=0.008, respectively). Conclusions: Smoking, longer duration of infertility, and elevated basal progesterone are poor prognostic factors for clinical pregnancy in clomiphene citrate and recombinant follicle-stimulating hormone cycles.
format Article
id doaj-art-228cc0dc45e8453b999a9b68739a6851
institution Kabale University
issn 1300-4751
2602-4918
language English
publishDate 2020-03-01
publisher Medical Network
record_format Article
series Gynecology Obstetrics & Reproductive Medicine
spelling doaj-art-228cc0dc45e8453b999a9b68739a68512025-02-11T21:27:20ZengMedical NetworkGynecology Obstetrics & Reproductive Medicine1300-47512602-49182020-03-0126110.21613/GORM.2019.978702Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center ExperienceBeril Gurlek0Ali Sertac Batioglu1Mine Kanat-Pektas2Ibrahim Kale3Ozgur Onal4Nafiye Yilmaz-Karakas5Department of Obstetrics and Gynecology, Recep Tayyip Erdogan University School of Medicine, RizeDepartment of Obstetrics and Gynecology, Uşak University School of Medicine, UşakDepartment of Obstetrics and Gynecology, Afyon Kocatepe University Hospital, AfyonkarahisarDepartment of Obstetrics and Gynecology, Ümraniye Training and Research Hospital, İstanbulDepartment of Public Health, Süleyman Demirel University School of Medicine, IspartaDepartment of Reproductive Endocrinology, Zekai Tahir Burak Women’s Health and Research Hospital, Ankara Objective: This aim of this study is to assess the ovulation induction cycles based on clomiphene citrate and gonadotropin administration and specify the factors associated with successful outcomes. Study Design: This is a prospective study of 631 patients who underwent 917 ovulation induction cycles. While clomiphene citrate was used in 680 cycles (74.2%) and recombinant follicle-stimulating hormone was administered in 237 cycles (25.8%). Results: A total of 153 pregnancies were achieved in 917 ovulation induction cycles, indicating a clinical pregnancy rate of 16.7%. The ovulation induction cycles which ended up with clinical pregnancy had a significantly lower frequency of smoking (p=0.005), shorter infertility duration (p=0.001), higher basal luteinizing hormone (p=0.021) and lower basal progesterone (p=0.008) than unsuccessful cycles. The clomiphene citrate cycles which ended up with clinical pregnancy had a significantly lower frequency of smoking (p=0.011), shorter infertility duration (p=0.001) and lower basal progesterone (p=0.013) than the unsuccessful cycles. The recombinant follicle-stimulating hormone cycles which ended up with clinical pregnancy had a significantly higher basal luteinizing hormone (p=0.008) than the unsuccessful cycles. Basal luteinizing hormone and progesterone concentrations could significantly distinguish the patients who were able to conceive in ovulation induction cycles (p=0.021 and p=0.008, respectively). Conclusions: Smoking, longer duration of infertility, and elevated basal progesterone are poor prognostic factors for clinical pregnancy in clomiphene citrate and recombinant follicle-stimulating hormone cycles. https://gorm.com.tr/index.php/GORM/article/view/978ClomipheneFollicle-stimulating hormoneOvulation inductionPregnancyProgesterone
spellingShingle Beril Gurlek
Ali Sertac Batioglu
Mine Kanat-Pektas
Ibrahim Kale
Ozgur Onal
Nafiye Yilmaz-Karakas
Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
Gynecology Obstetrics & Reproductive Medicine
Clomiphene
Follicle-stimulating hormone
Ovulation induction
Pregnancy
Progesterone
title Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
title_full Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
title_fullStr Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
title_full_unstemmed Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
title_short Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
title_sort success rates of clomiphene citrate and recombinant gonadotropin cycles a single center experience
topic Clomiphene
Follicle-stimulating hormone
Ovulation induction
Pregnancy
Progesterone
url https://gorm.com.tr/index.php/GORM/article/view/978
work_keys_str_mv AT berilgurlek successratesofclomiphenecitrateandrecombinantgonadotropincyclesasinglecenterexperience
AT alisertacbatioglu successratesofclomiphenecitrateandrecombinantgonadotropincyclesasinglecenterexperience
AT minekanatpektas successratesofclomiphenecitrateandrecombinantgonadotropincyclesasinglecenterexperience
AT ibrahimkale successratesofclomiphenecitrateandrecombinantgonadotropincyclesasinglecenterexperience
AT ozguronal successratesofclomiphenecitrateandrecombinantgonadotropincyclesasinglecenterexperience
AT nafiyeyilmazkarakas successratesofclomiphenecitrateandrecombinantgonadotropincyclesasinglecenterexperience